Recently Viewed

News Announcement

Cipla: Announcement under Regulation 30 (LODR)-Press Release / Media Release

31-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Cipla

Please find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan